The availability of a 750mcg teriparatide injection in the nation has slowly impacted treatment options for people with severe fragility fractures. Currently , this higher dosage medication is obtainable through limited healthcare providers and hospitals nationwide , depending on strict clinical guidelines. Turnover figures for the 750mcg therapy r